Topics

Orchard’s Gene Therapy Shows Potential in Treating Patients with Beta Thalassemia

12:35 EDT 30 Apr 2019 | Labiotech.eu

Patients with the life-threatening blood disorder beta-thalassemia required fewer blood transfusions after receiving a gene therapy developed by the UK company Orchard Therapeutics, with four out of nine no longer depending on transfusions. Beta thalassemia is a genetic disorder that affects hemoglobin, a protein that blood cells use to carry oxygen. In the most severe […]

The post Orchard’s Gene Therapy Shows Potential in Treating Patients with Beta Thalassemia appeared first on Labiotech.eu.

Original Article: Orchard’s Gene Therapy Shows Potential in Treating Patients with Beta Thalassemia

NEXT ARTICLE

More From BioPortfolio on "Orchard’s Gene Therapy Shows Potential in Treating Patients with Beta Thalassemia"

Quick Search

Relevant Topics

Biological Therapy
Biological therapy involves the use of living organisms, substances derived from living organisms, or laboratory-produced versions of such substances to treat disease. Some biological therapies for cancer use vaccines or bacteria to stimulate the body&rs...

Blood
Blood is a specialized bodily fluid that delivers necessary substances to the body's cells (in animals) – such as nutrients and oxygen – and transports waste products away from those same cells.  In vertebrates, it is composed of blo...

Nutrition
Within medicine, nutrition (the study of food and the effect of its components on the body) has many different roles. Appropriate nutrition can help prevent certain diseases, or treat others. In critically ill patients, artificial feeding by tubes need t...